The Efficacy and Safety of the Novel Long-Acting β 2 Agonist Vilanterol in Patients With COPD
- 1 July 2012
- journal article
- research article
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 142 (1), 119-127
- https://doi.org/10.1378/chest.11-2231
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Novel long‐acting bronchodilators for COPD and asthmaBritish Journal of Pharmacology, 2008
- Minimal Clinically Important Differences in COPD Lung FunctionCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2005